It was also found that bilateral intra-PL administration of KOR antagonist nor-BNI before behavioral test blocked depressive-like behaviors (Supplementary Fig. 11a–c), supporting a key role of KORs in depression. Here, OPRK1 is linked to depressive symptom measurement.